These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25740706)

  • 21. Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.
    Lu Y; Amleh A; Sun J; Jin X; McCullough SD; Baer R; Ren D; Li R; Hu Y
    Mol Endocrinol; 2007 Mar; 21(3):651-63. PubMed ID: 17185394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.
    Sankaran S; Starita LM; Simons AM; Parvin JD
    Cancer Res; 2006 Apr; 66(8):4100-7. PubMed ID: 16618730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha.
    Yang C; Li S; Wang M; Chang AK; Liu Y; Zhao F; Xiao L; Han L; Wang D; Li S; Wu H
    Mol Cancer; 2013 Mar; 12():21. PubMed ID: 23514585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.
    Atipairin A; Canyuk B; Ratanaphan A
    Breast Cancer Res Treat; 2011 Feb; 126(1):203-9. PubMed ID: 20878461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BARD1 regulates BRCA1-mediated transactivation of the p21WAF1/CIP1 and Gadd45 promoters.
    Fabbro M; Henderson BR
    Cancer Lett; 2008 May; 263(2):189-96. PubMed ID: 18243530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3).
    Kim JL; Ha GH; Campo L; Breuer EK
    Biochem Biophys Res Commun; 2018 Feb; 496(2):633-640. PubMed ID: 29355525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.
    Stebbing J; Zhang H; Xu Y; Lit LC; Green AR; Grothey A; Lombardo Y; Periyasamy M; Blighe K; Zhang W; Shaw JA; Ellis IO; Lenz HJ; Giamas G
    Oncogene; 2015 Apr; 34(16):2103-14. PubMed ID: 24909178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
    Calvo V; Beato M
    Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
    Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
    Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1/BARD1 complex interacts with steroidogenic factor 1--A potential mechanism for regulation of aromatase expression by BRCA1.
    Lu Y; Kang T; Hu Y
    J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):71-8. PubMed ID: 21087664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXK2 amplification promotes breast cancer development and chemoresistance.
    Yu Y; Cao WM; Cheng F; Shi Z; Han L; Yi J; da Silva EM; Dopeso H; Chen H; Yang J; Wang X; Zhang C; Zhang H
    Cancer Lett; 2024 Aug; 597():217074. PubMed ID: 38901667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.
    Vriend J; Reiter RJ
    Mol Cell Endocrinol; 2015 Dec; 417():1-9. PubMed ID: 26363225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
    Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
    J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
    Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
    Stewart MD; Duncan ED; Coronado E; DaRosa PA; Pruneda JN; Brzovic PS; Klevit RE
    Protein Sci; 2017 Mar; 26(3):475-483. PubMed ID: 27977889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.
    Wang X; Lu G; Li L; Yi J; Yan K; Wang Y; Zhu B; Kuang J; Lin M; Zhang S; Shao G
    Biochem Biophys Res Commun; 2014 Feb; 444(3):290-5. PubMed ID: 24342616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.
    Salas-Lloret D; García-Rodríguez N; Soto-Hidalgo E; González-Vinceiro L; Espejo-Serrano C; Giebel L; Mateos-Martín ML; de Ru AH; van Veelen PA; Huertas P; Vertegaal ACO; González-Prieto R
    Nat Commun; 2024 May; 15(1):4292. PubMed ID: 38769345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
    Brodie KM; Mok MTS; Henderson BR
    Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
    Baer R; Ludwig T
    Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.